Browse > Article
http://dx.doi.org/10.4014/jmb.1601.01043

Achieving High Yield of Lactic Acid for Antimicrobial Characterization in Cephalosporin-Resistant Lactobacillus by the Co-Expression of theosphofructokinase and Glucokinase  

Gong, Yahui (Institute of Genomic Medicine, College of Pharmacy, Jinan University)
Li, Tiyuan (Clinical Medical College of Jinan University)
Li, Shiyu (Institute of Genetic Engineering, Southern Medical University)
Jiang, Zhenyou (Departments of Microbiology and Immunology, Jinan University)
Yang, Yan (Institute of Genomic Medicine, College of Pharmacy, Jinan University)
Huang, Junli (Institute of Genomic Medicine, College of Pharmacy, Jinan University)
Liu, Zhaobing (Institute of Genomic Medicine, College of Pharmacy, Jinan University)
Sun, Hanxiao (Institute of Genomic Medicine, College of Pharmacy, Jinan University)
Publication Information
Journal of Microbiology and Biotechnology / v.26, no.6, 2016 , pp. 1148-1161 More about this Journal
Abstract
Lactobacilli are universally recognized as probiotics that are widely used in the adjuvant treatment of inflammatory diseases, such as vaginitis and enteritis. With the overuse of antibiotics in recent years, the lactobacilli in the human body are killed, which could disrupt the microecological balance in the human body and affect health adversely. In this work, cephalosporin-resistant Lactobacillus casei RL20 was obtained successfully from the feces of healthy volunteers, which possessed a stable genetic set. However, the shortage of lactic acid (72.0 g/l at 48 h) by fermentation did not meet the requirement for its use in medicine. To increase the production of lactic acid, the functional genes pfk and glk were introduced into the wild strain. A yield of 144.2 g/l lactic acid was obtained in the transgenic L. casei RL20-2 after fermentation for 48 h in 1 L of basic fermentation medium with an initial glucose concentration of 100 g/l and increasing antibacterial activity. These data suggested that L. casei RL20-2 that exhibited a high yield of lactic acid may be a potential probiotic to inhibit the spread of bacterial infectious diseases and may be used for vaginitis therapy.
Keywords
Antibacterial activity; cephalosporin resistance; lactic acid; Lactobacillus casei; microarray;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hays S, Jacquot A, Gauthier H, Kempf C, Beissel A, Pidoux O, et al. 2015. Probiotics and growth in preterm infants: a randomized controlled trial, PREMAPRO study. Clin. Nutr. DOI: 10.1016/j.clnu.2015.06.006.   DOI
2 Homayouni A, Bastani P, Ziyadi S, Mohammad-Alizadeh-Charandabi S, Ghalibaf M, Mortazavian AM, Mehrabany EV. 2014. Effects of probiotics on the recurrence of bacterial vaginosis: a review. J. Low. Genit. Tract Dis. 18: 79-86.   DOI
3 Hill MJ. 1997. Intestinal flora and endogenous vitamin synthesis. Eur. J. Cancer Prev. 1: S43-S45.   DOI
4 Jiang HX, Song L, Liu J, Zhang XH, Ren YN, Zhang WH, et al. 2014. Multiple transmissible genes encoding fluoroquinolone and third-generation cephalosporin resistance co-located in non-typhoidal Salmonella isolated from food-producing animals in China. Int. J. Antimicrob. Agents 43: 242-247.   DOI
5 Kadam SR, Patil SS, Bastawde KB, Khire JA, Gokhale DV. 2006. Strain improvement of Lactobacillus delbrueckii NCIM 2365 for lactic acid production. Process Biochem. 41: 120-126.   DOI
6 Tsuge Y, Yamamoto S, Suda M, Inui M, Yukawa H. 2013. Reactions upstream of glycerate-1,3-bisphosphate drive Corynebacterium glutamicum (D)-lactate productivity under oxygen deprivation. Appl. Microbiol. Biotechnol. 97: 6693-6703.   DOI
7 van der Steen M, Leenstra T, Kluytmans JA, van der Bij AK; ISIS-AR study group. 2015. Trends in expanded-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae among Dutch clinical isolates, from 2008 to 2012. PLoS One 10: e0138088.   DOI
8 Wang RF, Beggs ML, Erickson BD, Cerniglia CE. 2004. DNA microarray analysis of predominant human intestinal bacteria in fecal samples. Mol. Cell. Probes 18: 223-234.   DOI
9 Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. 2005. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115: 178-181.   DOI
10 Mitchell C, Balkus J, Agnew K, Lawler R, Hitti J. 2009. Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy. J. Women's Health 18: 1817-1824.   DOI
11 Lepelletier D, Richet H. 2001. Surveillance and control of methicillin-resistant Staphylococcus aureus infections in French hospitals. Infect. Control Hosp. Epidemiol. 22: 677-682.   DOI
12 Louie L, Goodfellow J, Mathieu P, Glatt A, Louie M, Simor AE. 2002. Rapid detection of methicillin-resistant staphylococci from blood culture bottles by using a multiplex PCR assay. J. Clin. Microbiol. 40: 2786-2790.   DOI
13 Zerr DM, Qin X, Oron AP, Adler AL, Wolter DJ, Berry JE, et al. 2014. Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae. Antimicrob. Agents Chemother. 58: 3997-4004.   DOI
14 Wang RF, Kim SJ, Robertson LH, Cerniglia CE. 2002. Development of a membrane-array method for the detection of human intestinal bacteria in fecal samples. Mol. Cell. Probes 16: 341-350.   DOI
15 Wilson AR, Sigee D, Epton HAS. 2005. Anti-bacterial activity of Lactobacillus plantarum strain SK1 against Listeria monocytogenes is due to lactic acid production. J. Appl. Microbiol. 99: 1516-1522.   DOI
16 Yu MC, Wang RC, Wang CY, Duan KJ, Sheu DC. 2007. Enhanced production of L(+)-lactic acid by floc-form culture of Rhizopus oryzae. J. Chin. Inst. Chem. Eng. 38: 223-228.   DOI
17 Perreten V, Vorlet FLP, Ehricht R, Kuhnert P, Frey J. 2006. Microarray-based detection of 90 antibiotic resistance genes of gram-positive bacteria. J. Clin. Microbiol. 43: 2291-2302.   DOI
18 Ness RB, Hillier SL, Kip KE, Soper DE, Stamm CA, McGregor JA, et al. 2004. Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet. Gynecol. 104: 761-769.   DOI
19 Meakins S, Fisher IS, Berghold C, Gerner-Smidt P, Tschäpe H, Cormican M, et al. 2008. Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000-2004: a report from the Enter-net International Surveillance Network. Microbiol. Drug Resist. 14: 31-35.   DOI
20 Meyer E, Schwab F, Schroeren-Boersch B, Gastmeier P. 2010. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit. Care 14: R113.   DOI
21 Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. 2011. Vaginal microbiome of reproductiveage women. Proc. Natl. Acad. Sci. USA 1: 4680-4687.   DOI
22 Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S. 2015. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front. Physiol. 6: 81.   DOI
23 Tagg JR, Dierksen KP. 2003. Bacterial replacement therapy: adapting ‘germ warfare’ to infection prevention. Trends Biotechnol. 21: 217-223.   DOI
24 Thibaut S, Caillon J, Marquet A, Grandjean G, Potel G, Ballereau F; Microbiology Laboratories of MedQual Network. 2014. Epidemiology of third-generation cephalosporin-resistant community-acquired Enterobacteria isolated from elderly patients. Med. Mal. Infect. 44: 57-62.   DOI
25 Salvetti E, Torriani S, Felis GE. 2012. The genus Lactobacillus: a taxonomic update. Probiotics Antimicrob. Proteins 4: 217-226.   DOI
26 Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, et al. 2010. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One 5: e10197.   DOI
27 Tsuge Y, Yamamoto S, Kato N, Suda M, Vertes AA, Yukawa H, Inui M. 2015. Overexpression of the phosphofructokinase encoding gene is crucial for achieving high production of D-lactate in Corynebacterium glutamicum under oxygen deprivation. Appl. Microbiol. Biotechnol. 99: 4679-4689.   DOI
28 Strus M, Kucharska A, Kukla G, Brzychczy-Wloch M, Maresz K, Heczko PB. 2005. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect. Dis. Obstet. Gynecol. 13: 69-75.   DOI
29 Blaser M. 2011. Antibiotic overuse: stop the killing of beneficial bacteria. Nature 476: 393-394.   DOI
30 Datta R, Tsai SP, Bonsignore P, Moon SH, Frank JR. 1993. Technological and economic potential of poly (lactic acid) and lactic acid derivatives, pp. 221-231. In: Proceedings of the 8th International Trade Fair for Biotechnology: Research, Equipment, Production, Agriculture, Environment, Food & Health. Hannover (Germany).
31 Georgieva R, Yocheva L, Tserovska L, Zhelezova G, Stefanova N, Atanasova A, et al. 2015. Antimicrobial activity and antibiotic susceptibility of Lactobacillus and Bifidobacterium spp. intended for use as starter and probiotic cultures. Biotechnol. Biotechnol. Equip. 29: 84-91.   DOI
32 Amara AA, Shibl A. 2015. Role of probiotics in health improvement, infection control and disease treatment and management. Saudi Pharm. J. 23: 107-114.   DOI
33 Goldstein EJC, Tyrrell KL, Citron DM. 2015. Lactobacillus species: taxonomic complexity and controversial susceptibilities. Clin. Infect. Dis. 60: S98-S107.   DOI
34 Asai T, Masani K, Sato C, Hiki M, Usui M, Baba K, et al. 2011. Phylogenetic groups and cephalosporin resistance genes of Escherichia coli from diseased food-producing animals in Japan. Acta Vet. Scand. 53: 1-5.   DOI